<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28842414</article-id>
<article-id pub-id-type="pmc">5607470</article-id>
<article-id pub-id-type="publisher-id">1582-17</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.1582-17.2017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bermingham</surname>
<given-names>Daniel P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3893-2658</contrib-id>
<name>
<surname>Hardaway</surname>
<given-names>J. Andrew</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-5870-5236</contrib-id>
<name>
<surname>Refai</surname>
<given-names>Osama</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9232-5261</contrib-id>
<name>
<surname>Marks</surname>
<given-names>Christian R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Snider</surname>
<given-names>Sam L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2076-3043</contrib-id>
<name>
<surname>Sturgeon</surname>
<given-names>Sarah M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-9700-8011</contrib-id>
<name>
<surname>Spencer</surname>
<given-names>William C.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7401-8244</contrib-id>
<name>
<surname>Colbran</surname>
<given-names>Roger J.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miller</surname>
<given-names>David M.</given-names>
<suffix>III</suffix>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2182-6966</contrib-id>
<name>
<surname>Blakely</surname>
<given-names>Randy D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Departments of Pharmacology, </aff>
<aff id="aff2"><sup>2</sup>Molecular Physiology and Biophysics, </aff>
<aff id="aff3"><sup>3</sup>Cell and Developmental Biology, and </aff>
<aff id="aff4"><sup>4</sup>Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, and </aff>
<aff id="aff5"><sup>5</sup>Department of Biomedical Sciences and </aff>
<aff id="aff6"><sup>6</sup>Brain Institute, Florida Atlantic University, Jupiter, Florida 33458</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Randy D. Blakely,
<addr-line>MC-17, Room 109, FAU Brain Institute, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458.</addr-line><email>rblakely@health.fau.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: D.P.B., J.A.H., O.R., C.R.M., R.J.C., and R.D.B. designed research; D.P.B., J.A.H., O.R., C.R.M., S.L.S., and S.M.S. performed research; R.J.C., D.M.M., and R.D.B. contributed unpublished reagents/analytic tools; D.P.B., J.A.H., O.R., C.R.M., S.L.S., W.C.S., R.J.C., D.M.M., and R.D.B. analyzed data; D.P.B. and R.D.B. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>20</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>3</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>37</volume>
<issue>38</issue>
<fpage>9288</fpage>
<lpage>9304</lpage>
<history>
<date date-type="received">
<day>5</day>
<month>6</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2017 the authors 0270-6474/17/379288-17$15.00/0</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns03817009288.pdf"></self-uri>
<abstract>
<p>The neurotransmitter dopamine (DA) regulates multiple behaviors across phylogeny, with disrupted DA signaling in humans associated with addiction, attention-deficit/ hyperactivity disorder, schizophrenia, and Parkinson's disease. The DA transporter (DAT) imposes spatial and temporal limits on DA action, and provides for presynaptic DA recycling to replenish neurotransmitter pools. Molecular mechanisms that regulate DAT expression, trafficking, and function, particularly <italic>in vivo</italic>, remain poorly understood, though recent studies have implicated rho-linked pathways in psychostimulant action. To identify genes that dictate the ability of DAT to sustain normal levels of DA clearance, we pursued a forward genetic screen in <italic>Caenorhabditis elegans</italic> based on the phenotype swimming-induced paralysis (Swip), a paralytic behavior observed in hermaphrodite worms with loss-of-function <italic>dat-1</italic> mutations. Here, we report the identity of <italic>swip-13</italic>, which encodes a highly conserved ortholog of the human atypical MAP kinase ERK8. We present evidence that SWIP-13 acts presynaptically to insure adequate levels of surface DAT expression and DA clearance. Moreover, we provide <italic>in vitro</italic> and <italic>in vivo</italic> evidence supporting a conserved pathway involving SWIP-13/ERK8 activation of Rho GTPases that dictates DAT surface expression and function.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Signaling by the neurotransmitter dopamine (DA) is tightly regulated by the DA transporter (DAT), insuring efficient DA clearance after release. Molecular networks that regulate DAT are poorly understood, particularly <italic>in vivo</italic>. Using a forward genetic screen in the nematode <italic>Caenorhabditis elegans</italic>, we implicate the atypical mitogen activated protein kinase, SWIP-13, in DAT regulation. Moreover, we provide <italic>in vitro</italic> and <italic>in vivo</italic> evidence that SWIP-13, as well as its human counterpart ERK8, regulate DAT surface availability via the activation of Rho proteins. Our findings implicate a novel pathway that regulates DA synaptic availability and that may contribute to risk for disorders linked to perturbed DA signaling. Targeting this pathway may be of value in the development of therapeutics in such disorders.</p>
</abstract>
<kwd-group>
<kwd>
<italic>C. elegans</italic>
</kwd>
<kwd>dopamine</kwd>
<kwd>genetics</kwd>
<kwd>kinase</kwd>
<kwd>neurotransmitters</kwd>
<kwd>transporters</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>